FDA Issues Warnings on Unapproved Use of Retatrutide Amid Legislative Action | Retatrutide News

The FDA has warned against the unapproved use of retatrutide as a new Compounding Oversight Bill advances. This highlights the importance of regulatory ...
Market News · November 3, 2026